Home » Stocks » MASI

Masimo Corporation (MASI)

Stock Price: $250.73 USD 4.62 (1.88%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $250.88 +0.15 (0.06%) Feb 26, 7:47 PM
Market Cap 13.86B
Revenue (ttm) 1.14B
Net Income (ttm) 240.30M
Shares Out 54.70M
EPS (ttm) 4.14
PE Ratio 60.56
Forward PE 59.52
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $250.73
Previous Close $246.11
Change ($) 4.62
Change (%) 1.88%
Day's Open 247.09
Day's Range 244.96 - 251.76
Day's Volume 397,960
52-Week Range 143.90 - 284.86

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 3 days ago

Masimo (MASI) continues to gain from its key Product segment, which witnessed solid growth in Q4.

Business Wire - 3 days ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Raymond James 42nd Annual Institutional Investors Conference on We...

Benzinga - 4 days ago

Shares of Masimo (NASDAQ:MASI) fell  in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 7.69% year over year to $0.98, which beat the...

Business Wire - 4 days ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 2, 2021. Fourth Quarter 2020 Results: Total reve...

Business Wire - 4 days ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo softFlow®, innovative high-flow nasal cannula therapy, is now available in the U.S. for spontaneously breathing adult patients.

Zacks Investment Research - 5 days ago

Masimo Corporation (MASI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 days ago

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Other stocks mentioned: BSX, COO, HOLX, LH, MDT, XRAY
Zacks Investment Research - 1 week ago

Masimo (MASI) SafetyNet-OPEN aids organizations in detecting those who are most vulnerable to COVID-19.

Business Wire - 1 week ago

IRVINE, Calif.--(BUSINESS WIRE)--As previously announced on January 13, Masimo (NASDAQ: MASI) will release fourth quarter and full year 2020 financial results for the period ended January 2, 2...

Business Wire - 1 week ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo SafetyNet-OPEN™, a web and mobile app solution that helps organizations stay open safely during COVID-19 and beyond, has full market release.

Zacks Investment Research - 2 weeks ago

Latest study favors Medtronic's (MDT) Nellcor Pulse Oximetry for all newborns considered for study, unlike from those newborns with Masimo's oximeter.

Other stocks mentioned: MDT
Business Wire - 2 weeks ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital Health Conference on Thursday, February 1...

Zacks Investment Research - 3 weeks ago

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Business Wire - 3 weeks ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo has successfully completed the acquisition of LiDCO, a leading provider of advanced hemodynamic monitoring systems.

Seeking Alpha - 4 weeks ago

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and p...

Other stocks mentioned: ANNX, ASA, BME, BMEZ, BST, BSTZ, GMAB, GNMSF, KYMR, OSH, SGEN, SGTX, TSHA
Zacks Investment Research - 1 month ago

Masimo's (MASI) iSirona helps in efficient workflow in hospitals by providing continuous connectivity, thereby helping clinicians to improve patient outcomes.

Business Wire - 1 month ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo announced iSirona™, a compact, versatile, connectivity hub that routes data from medical devices to the Masimo Hospital Automation™ platform.

Zacks Investment Research - 1 month ago

Per the preliminary announcement, Masimo (MASI) projects 2020 product revenues to improve.

Zacks Investment Research - 1 month ago

The booming digital health space has been witnessing significant M&A activities amid the pandemic.

Other stocks mentioned: AMN, PHG, RCM
Business Wire - 1 month ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial and operational results for the full-year ended January 2, 2021 and provided est...

Zacks Investment Research - 2 months ago

Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

Business Wire - 2 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo is helping Renown Health address the COVID-19 surge, in part through use of Masimo SafetyNet™, a remote patient management solution.

Zacks Investment Research - 2 months ago

Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.

Business Wire - 2 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study used Masimo ORi™, Oxygen Reserve Index, to help limit the extent of postoperative hyperoxia.

Business Wire - 2 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--In a study of pediatric patients, Masimo SpHb® was associated with improved outcomes, including reduced postoperative transfusion and ICU stays.

Business Wire - 2 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo was featured at CLSA's Pantheon 2020 conference for its efforts to help clinicians and hospitals combat COVID-19.

Business Wire - 2 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on Wednesday, December...

Business Wire - 2 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study of mechanically ventilated patients compared Masimo PVi® to another noninvasive fluid responsiveness indicator and found PVi advantageous.

Business Wire - 3 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020...

Business Wire - 3 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A cancer study using a PBM program with Masimo SpHb® found decreased RBC units transfused per patient and increased transfusion appropriateness.

Business Wire - 3 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Joe Kiani, Founder & CEO of Masimo & co-inventor of measure-through-motion pulse oximetry, was honored by SIBEN for improvements to neonatal health.

GuruFocus - 3 months ago

There are many useful nooks and crannies on the GuruFocus website, including screeners that help us find stocks outside the mainstream.

Other stocks mentioned: EW, FNV
Business Wire - 3 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Radius VSM™, a versatile, expandable, wearable, tetherless vital signs monitor, has received CE marking and limited market release in Europe.

Zacks Investment Research - 3 months ago

Masimo (MASI) continues to gain from key Product segment, which witnessed solid growth in Q3.

Seeking Alpha - 4 months ago

Masimo Corporation (MASI) CEO Joe Kiani on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Masimo (MASI) delivered earnings and revenue surprises of 42.86% and 1.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 4 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the third quarter ended September 26, 2020. Third Quarter 2020 Results: Total revenue, includin...

Investors Business Daily - 4 months ago

Masimo is trading near a potential buy area ahead of its next quarterly earnings report, expected on or around Oct. 27. The post Masimo Near Later-Stage Buy Point Ahead Of Earnings Report appe...

Zacks Investment Research - 4 months ago

Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2020 financial results for the period ended September 26, 2020, after the market closes on Tuesday, October 27...

Zacks Investment Research - 4 months ago

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Investors Business Daily - 4 months ago

Masimo is near a buy zone with earnings due on or around Oct. 27. The post Highly Rated Masimo Forms Later-Stage Base With Earnings Due appeared first on Investor's Business Daily.

Business Wire - 4 months ago

NEUCHATEL, Switzerland--(BUSINESS WIRE)--In an ASA abstract, researchers investigated whether Masimo ORi™ could predict the need for postoperative oxygen therapy in children with sleep apnea.

Zacks Investment Research - 4 months ago

Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.

Investors Business Daily - 4 months ago

Masimo, a maker medical devices that include a Covid-19 monitor, finally gave its first 2020 guidance and also posted preliminary third-quarter sales that beat expectation; MASI stock rose. Th...

GuruFocus - 4 months ago

According to the All-in-One Screener, a Premium feature of GuruFocus, five stalwarts that have high financial strength and expanding operating margins include Mastech Digital Inc. (MHH), Colum...

Other stocks mentioned: COLM, EW, MED, MHH
Business Wire - 4 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the third quarter ended September 26, 2020, and provided select fina...

Business Wire - 4 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo is launching the wearable, wireless Radius Tº™ Continuous Thermometer for consumers.

GuruFocus - 4 months ago

New Historical Data Screen identifies stocks with high returns over the past 5 years

Other stocks mentioned: AAPL, CPRT, EXPO
Business Wire - 4 months ago

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Rad-G™, which provides spot-checking and continuous monitoring with SET® pulse oximetry and other parameters, has received FDA clearance.

About MASI

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen satura... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Aug 8, 2007
CEO
Joseph Kiani
Employees
2,000
Stock Exchange
NASDAQ
Ticker Symbol
MASI
Full Company Profile

Financial Performance

In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.

Financial Statements

Analyst Forecasts

According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 297.83, which is an increase of 18.79% from the latest price.

Price Target
$297.83
(18.79% upside)
Analyst Consensus: Buy